Themis Medicare Limited

NSE:THEMISMED.NS

263.95 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 3,817.6083,543.2333,946.1412,306.6982,015.8831,837.5472,095.0332,458.0152,327.9742,018.8151,950.661,734.9631,576.3972,502.7842,283.6082,145.3412,386.1041,775.98
Cost of Revenue 2,313.7041,183.6491,519.946805.33648.706695.231730.055830.136873.519923.51862.369816.5651,461.5632,274.691,964.092,079.0872,072.961,530.736
Gross Profit 1,503.9042,359.5842,426.1951,501.3681,367.1771,142.3161,364.9781,627.8791,454.4551,095.3051,088.291918.398114.834228.094319.51866.254313.144245.244
Gross Profit Ratio 0.3940.6660.6150.6510.6780.6220.6520.6620.6250.5430.5580.5290.0730.0910.140.0310.1310.138
Reseach & Development Expenses 136.871142.544136.37584.96734.32145.84652.83551.3835.05326.63716.60220.204000000
General & Administrative Expenses 108.97993.44599.22166.85344.58461.86562.24559.81340.186329.20923.87327.909000000
Selling & Marketing Expenses 223.59170.302260.776149.2181.364132.151145.172111.06150.51831.783100.57676.463000000
SG&A 1,111.315263.747359.997216.063125.948194.016207.417170.873190.704360.992525.806455.082000000
Other Expenses 47.555115.04812.6466.81529.1131.1738.8586.0548.971114.5631.18620.496288.9271.97228.8287.4520.23531.515
Operating Expenses 1,111.3151,790.0231,564.6431,091.91,092.6191,199.3081,186.7791,259.6141,087.6581,016.548939.099839.937288.9271.97228.8287.4520.23531.515
Operating Income 392.589820.793861.552409.468274.558-56.992178.199368.265366.79778.757149.19278.461-174.093226.122290.6958.804292.909213.729
Operating Income Ratio 0.1030.2320.2180.1780.136-0.0310.0850.150.1580.0390.0760.045-0.110.090.1270.0270.1230.12
Total Other Income Expenses Net -46.211-95.64491.0683.839-5.812-68.98-64.839-173.06-171.566-18.723-112.616-119.079-158.7-103.073-83.705-152.697-94.689-79.483
Income Before Tax 346.378725.149952.62413.307268.746-125.972113.36195.205195.23160.03436.576-40.618-332.793123.049206.985-93.893198.22134.246
Income Before Tax Ratio 0.0910.2050.2410.1790.133-0.0690.0540.0790.0840.030.019-0.023-0.2110.0490.091-0.0440.0830.076
Income Tax Expense 99.197156.141223.81356.27820.93-18.3741.0186.80112.58217.71413.1187.1065.05920.7430.55817.54316.42726.62
Net Income 435.238569.01728.808357.03247.817-107.416112.971194.899193.22950.06323.458-47.724-337.85299.835205.857-113.551180.152106.589
Net Income Ratio 0.1140.1610.1850.1550.123-0.0580.0540.0790.0830.0250.012-0.028-0.2140.040.09-0.0530.0760.06
EPS 4.736.187.923.892.7-1.1712.2817.6619.127.343.19-5.93-41.9714.1625.57-14.122.3813.24
EPS Diluted 4.726.177.913.882.7-1.1712.2817.6618.967.243.05-5.93-41.9714.1625.57-14.122.3813.24
EBITDA 515.052925.7411,112.448608.247462.89758.118292.609388.426414.408301.565242.748164.629-96.148304.67368.167137.446356.714265.128
EBITDA Ratio 0.1350.2610.2820.2640.230.0320.140.1580.1780.1490.1240.095-0.0610.1220.1610.0640.1490.149